IPA   $0.53  -1.85% Market Open

Immunoprecise Antibodies Ltd
Total Cash 3.91M
totalCashPerShare 0.14
EBITDA -11.51M
Total Debt 16.10M
quickRatio 0.665
currentRatio 0.986
Total Revenue 24.09M
debtToEquity 49.005
Revenue/Share 0.921
ROA -0.13452
ROE -0.64038
grossProfits
freeCashflow -808.50K
operatingCashflow -5.52M
earningsGrowth
revenueGrowth -0.075
grossMargins 0.48205003
ebitdaMargins -0.47752
operatingMargins -0.86225
profitMargins -1.1522
enterpriseValue 23.17M
forwardPE -2.458125
floatShares 24.54M
sharesOutstanding 28.83M
sharesShort 146.08K
sharesShortPriorMonth 109.81K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.06%
Short Ratio help_outline 0.45%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.203
Price To Book help_outline 0.33
earningsQuarterlyGrowth
netIncomeToCommon -27.76M
trailingEps -0.72%
forwardEps -0.16%
enterpriseToEbitda -2.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 4Q 2024
institutionsCount 21
lastUpdated Nov. 7, 2024, 4:48 a.m.